Beijing Foyou Pharma CO.,LTD (SHA:601089)
China flag China · Delayed Price · Currency is CNY
20.64
-0.23 (-1.10%)
At close: Apr 28, 2026

SHA:601089 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
595.93634.36794.072,5312,541434.69
Trading Asset Securities
1,5431,4291,579--100
Cash & Short-Term Investments
2,1392,0632,3732,5312,541534.69
Cash Growth
-4.72%-13.06%-6.23%-0.41%375.27%66.97%
Accounts Receivable
458.03522.56452.08346.13396.47337.99
Other Receivables
1.631.421.2100.2374.7757.66
Receivables
459.66523.98453.28446.37471.24395.65
Inventory
425.01412.66347.56307.42339.1324
Other Current Assets
54.1452.727.2644.1420.7925.08
Total Current Assets
3,0783,0533,2013,3293,3721,279
Property, Plant & Equipment
1,6951,6901,426983.41779.77721.73
Other Intangible Assets
136.73139.79139.21150.2142.61144.24
Long-Term Deferred Tax Assets
4.664.393.312.814.724.39
Long-Term Deferred Charges
10.721321.8222.9217.650.33
Other Long-Term Assets
10.0724.3725.3459.714.863.08
Total Assets
4,9354,9244,8174,5484,3222,153
Accounts Payable
250.95258.49286.76132.18143.51129.77
Accrued Expenses
94.68643.22676.84607.02598.17472.26
Short-Term Debt
--40.0355.0540.0570.09
Current Portion of Long-Term Debt
14.41--4.954.957.01
Current Portion of Leases
-16.7614.3319.6616.2610.56
Current Income Taxes Payable
37.8810.8525.8319.2939.6517.34
Current Unearned Revenue
49.6523.8836.5939.7480.9642.82
Other Current Liabilities
519.0598.1109.55120.48129.46116.64
Total Current Liabilities
966.621,0511,190998.381,053866.48
Long-Term Debt
---12.3717.337.28
Long-Term Leases
5.58920.7932.2644.3343.06
Long-Term Unearned Revenue
50.1449.0634.4910.029.54.14
Long-Term Deferred Tax Liabilities
23.5421.7915.3318.2218.8516.9
Total Liabilities
1,0461,1311,2611,0711,143937.86
Common Stock
480480480480480360
Additional Paid-In Capital
1,6621,6621,6621,6621,662146.47
Retained Earnings
1,8981,8031,5671,3141,017686.08
Treasury Stock
-176.19-176.19-176.19---
Comprehensive Income & Other
10.3610.3910.9812.3415.118.94
Total Common Equity
3,8753,7793,5453,4683,1741,211
Minority Interest
14.2113.4211.538.124.553.83
Shareholders' Equity
3,8893,7933,5563,4773,1791,215
Total Liabilities & Equity
4,9354,9244,8174,5484,3222,153
Total Debt
2025.7675.16124.3122.92137.99
Net Cash (Debt)
2,1192,0372,2982,4072,418396.7
Net Cash Growth
-3.87%-11.34%-4.51%-0.49%509.62%67.76%
Net Cash Per Share
4.534.344.895.025.731.10
Filing Date Shares Outstanding
477.06468468480480360
Total Common Shares Outstanding
477.06468468480480360
Working Capital
2,1112,0012,0112,3302,319412.94
Book Value Per Share
8.128.087.577.236.613.37
Tangible Book Value
3,7383,6403,4053,3183,0321,067
Tangible Book Value Per Share
7.847.787.286.916.322.96
Buildings
-1,288523.07520.3506.03443.93
Machinery
-911.52609.64558.75511.19416.4
Construction In Progress
-19.27719.15255.6646.72100.06
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.